• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种后个体不良事件因果关系评估算法。

Algorithm to assess causality after individual adverse events following immunizations.

机构信息

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

出版信息

Vaccine. 2012 Aug 24;30(39):5791-8. doi: 10.1016/j.vaccine.2012.04.005. Epub 2012 Apr 14.

DOI:10.1016/j.vaccine.2012.04.005
PMID:22507656
Abstract

Assessing individual reports of adverse events following immunizations (AEFI) can be challenging. Most published reviews are based on expert opinions, but the methods and logic used to arrive at these opinions are neither well described nor understood by many health care providers and scientists. We developed a standardized algorithm to assist in collecting and interpreting data, and to help assess causality after individual AEFI. Key questions that should be asked during the assessment of AEFI include: Is the diagnosis of the AEFI correct? Does clinical or laboratory evidence exist that supports possible causes for the AEFI other than the vaccine in the affected individual? Is there a known causal association between the AEFI and the vaccine? Is there strong evidence against a causal association? Is there a specific laboratory test implicating the vaccine in the pathogenesis? An algorithm can assist with addressing these questions in a standardized, transparent manner which can be tracked and reassessed if additional information becomes available. Examples in this document illustrate the process of using the algorithm to determine causality. As new epidemiologic and clinical data become available, the algorithm and guidelines will need to be modified. Feedback from users of the algorithm will be invaluable in this process. We hope that this algorithm approach can assist with educational efforts to improve the collection of key information on AEFI and provide a platform for teaching about causality assessment.

摘要

评估疫苗接种后不良反应事件(AEFI)的个体报告可能具有挑战性。大多数已发表的综述基于专家意见,但许多医疗保健提供者和科学家并不了解用于得出这些意见的方法和逻辑。我们开发了一种标准化算法,以协助收集和解释数据,并帮助评估个体 AEFI 后的因果关系。在评估 AEFI 时应提出的关键问题包括:AEFI 的诊断是否正确?在受影响的个体中,除了疫苗外,是否存在支持 AEFI 其他可能原因的临床或实验室证据?AEFI 与疫苗之间是否存在已知的因果关系?是否有强有力的证据表明不存在因果关系?是否有特定的实验室检测表明疫苗在发病机制中起作用?算法可以帮助以标准化、透明的方式解决这些问题,并且如果有更多信息可用,还可以进行跟踪和重新评估。本文档中的示例说明了使用算法确定因果关系的过程。随着新的流行病学和临床数据的出现,算法和指南将需要进行修改。算法用户的反馈在这一过程中是非常宝贵的。我们希望这种算法方法可以帮助提高 AEFI 关键信息的收集,并为因果关系评估教学提供一个平台。

相似文献

1
Algorithm to assess causality after individual adverse events following immunizations.疫苗接种后个体不良事件因果关系评估算法。
Vaccine. 2012 Aug 24;30(39):5791-8. doi: 10.1016/j.vaccine.2012.04.005. Epub 2012 Apr 14.
2
Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.疫苗不良反应(AEFI)个体不良事件因果关系评估:全球使用的世卫组织工具。
Vaccine. 2013 Oct 17;31(44):5041-6. doi: 10.1016/j.vaccine.2013.08.087. Epub 2013 Sep 8.
3
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.理解人类变异在疫苗不良反应中的作用:临床免疫安全评估网络。
Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.
4
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).向疫苗不良事件报告系统(VAERS)报告的不良事件的因果关系评估。
Vaccine. 2012 Nov 26;30(50):7253-9. doi: 10.1016/j.vaccine.2012.09.074. Epub 2012 Oct 9.
5
Adverse events following immunization: is this time for the use of WHO causality assessment?免疫接种后的不良事件:现在是使用世界卫生组织因果关系评估的时候了吗?
Expert Rev Vaccines. 2015 May;14(5):625-7. doi: 10.1586/14760584.2015.1029460. Epub 2015 Mar 25.
6
Application of the revised WHO causality assessment protocol for adverse events following immunization in India.经修订的世界卫生组织免疫接种后不良事件因果关系评估方案在印度的应用。
Vaccine. 2017 Jul 24;35(33):4197-4202. doi: 10.1016/j.vaccine.2017.06.027. Epub 2017 Jun 22.
7
Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.加强世界卫生组织东南亚和西太平洋区域免疫接种后不良事件的因果关系评估:2014年东南亚区域国家间研讨会的经验教训
Vaccine. 2015 Nov 27;33(48):6902-7. doi: 10.1016/j.vaccine.2015.01.033. Epub 2015 Jan 21.
8
[Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].[2008年布基纳法索黄热病免疫接种后不良事件监测系统。良好实践建议]
Med Trop (Mars). 2009 Aug;69(4):320-1.
9
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
10
Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.瑞士免疫接种后不良反应(AEFI)监测-1991-2001 年。
Vaccine. 2010 May 28;28(24):4059-64. doi: 10.1016/j.vaccine.2010.04.002. Epub 2010 Apr 18.

引用本文的文献

1
The potential association between herpes zoster and COVID-19 vaccination.带状疱疹与新冠病毒疫苗接种之间的潜在关联。
Heliyon. 2024 Feb 8;10(4):e25738. doi: 10.1016/j.heliyon.2024.e25738. eCollection 2024 Feb 29.
2
Self-reported side effects following COVID-19 vaccination in athletes: A retrospective study.运动员接种 COVID-19 疫苗后的自述副作用:一项回顾性研究。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2234788. doi: 10.1080/21645515.2023.2234788.
3
Observational Study of Patients Hospitalized With Neurologic Events After SARS-CoV-2 Vaccination, December 2020-June 2021.
2020年12月至2021年6月接种SARS-CoV-2疫苗后发生神经系统事件住院患者的观察性研究。
Neurol Clin Pract. 2023 Aug;13(4):e200166. doi: 10.1212/CPJ.0000000000200166. Epub 2023 May 25.
4
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.评估大流行期间的疫苗安全性:未来的最新经验和教训。
Vaccine. 2023 Jun 7;41(25):3790-3795. doi: 10.1016/j.vaccine.2023.04.055. Epub 2023 May 15.
5
Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review.新冠病毒疫苗会增加水痘带状疱疹病毒再激活的风险吗?一项系统性综述。
J Cosmet Dermatol. 2021 Nov;20(11):3350-3361. doi: 10.1111/jocd.14521.
6
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2.接种新冠病毒疫苗后水痘带状疱疹病毒的再激活
Vaccines (Basel). 2021 Jun 1;9(6):572. doi: 10.3390/vaccines9060572.
7
Why is it so hard to investigate the rare side effects of COVID vaccines?为什么调查新冠疫苗的罕见副作用如此困难?
Nature. 2021 Apr 1. doi: 10.1038/d41586-021-00880-9.
8
Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018.2014 - 2018年二价B群脑膜炎球菌疫苗的安全性监测,疫苗不良事件报告系统
Open Forum Infect Dis. 2020 Oct 27;7(12):ofaa516. doi: 10.1093/ofid/ofaa516. eCollection 2020 Dec.
9
Immune-mediated adverse reactions to vaccines.疫苗免疫介导的不良反应。
Br J Clin Pharmacol. 2019 Dec;85(12):2694-2706. doi: 10.1111/bcp.14112. Epub 2019 Nov 5.
10
Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data.水痘减毒活疫苗:上市后安全性数据的22年回顾
Open Forum Infect Dis. 2019 Aug 1;6(8). doi: 10.1093/ofid/ofz295.